Nebenwirkungen · Abilify Maintena
Abilify Maintena 720 mg prolonged-release suspension for injection in pre-filled syringe Abilify Maintena 960 mg prolonged-release suspension for injection in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 33
HOS-129466 · Präparat HOS-096717
Respiratory, Cough Oropharyngeal spasm thoracic and Hiccups Laryngospasm mediastinal Aspiration pneumonia disorders Gastrointestinal Dry mouth Gastrooesophageal Pancreatitis disorders reflux disease Dysphagia Dyspepsia Vomiting Diarrhoea Nausea Abdominal pain upper Abdominal discomfort Constipation Frequent bowel movements Salivary hypersecretion Hepatobiliary Liver function test Hepatic failure disorders abnormal Jaundice Hepatic enzyme Hepatitis increased Alkaline phosphatase Alanine increased aminotransferase increased Gamma- glutamyltransferase increased Blood bilirubin increased Aspartate aminotransferase increased Skin and Alopecia Rash subcutaneous tissue Acne Photosensitivity disorders Rosacea reaction Eczema Hyperhidrosis Skin induration Drug reaction with eosinophilia and systemic symptoms (DRESS) Musculoskeletal Musculoskeletal Muscle rigidity Rhabdomyolysis and connective stiffness Muscle spasms tissue disorders Muscle twitching Muscle tightness Myalgia Pain in extremity Arthralgia Back pain Joint range of motion decreased Nuchal rigidity Trismus Renal and urinary Nephrolithiasis Urinary retention disorders Glycosuria Urinary incontinence
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-10-28T15:16:00Z · SHA-256 41ea025269b746fee63511b9edbf4ea222d53988b45b27fd317f27f82cafb4fe · Passage c71c01cd2e8cbd7b77f174c7853551b6755af00fb88bbf2aefa5538f36b2b0e4 · Zeichen 7183–10592 im Abschnitt